164 related articles for article (PubMed ID: 21481261)
1. Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma.
Andolfo I; Petrosino G; Vecchione L; De Antonellis P; Capasso M; Montanaro D; Gemei M; Troncone G; Iolascon A; Orditura M; Ciardiello F; De Vita F; Zollo M
BMC Cancer; 2011 Apr; 11():126. PubMed ID: 21481261
[TBL] [Abstract][Full Text] [Related]
2. Copy number loss of variation_91720 in PIK3CA predicts risk of esophageal squamous cell carcinoma.
Wu Y; Liu X; Hu L; Tao H; Guan X; Zhang K; Bai Y; Yang K
Int J Clin Exp Pathol; 2015; 8(11):14479-85. PubMed ID: 26823766
[TBL] [Abstract][Full Text] [Related]
3. ERBB2 gene amplification in oral squamous cell malignancies: a correlation with tumor progression and gene expression.
Chu F; Feng Q; Qian Y; Zhang C; Fang Z; Shen G
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jul; 112(1):90-5. PubMed ID: 21531597
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic pathology of early systemic cancer: ERBB2 gene amplification in single disseminated cancer cells determines patient survival in operable esophageal cancer.
Hoffmann M; Pasch S; Schamberger T; Maneck M; Möhlendick B; Schumacher S; Brockhoff G; Knoefel WT; Izbicki J; Polzer B; Stoecklein NH; Klein CA
Int J Cancer; 2018 Feb; 142(4):833-843. PubMed ID: 29044505
[TBL] [Abstract][Full Text] [Related]
5. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients.
Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q
BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149
[TBL] [Abstract][Full Text] [Related]
6. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis.
Yang YF; Li H; Xu XQ; Diao YT; Fang XQ; Wang Y; Zhao DL; Wu K; Li HQ
Dis Esophagus; 2008; 21(5):395-401. PubMed ID: 19125792
[TBL] [Abstract][Full Text] [Related]
7. Circulating Cell-Free DNA Levels Could Predict Oncological Outcomes of Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma.
Hsieh CC; Hsu HS; Chang SC; Chen YJ
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999323
[TBL] [Abstract][Full Text] [Related]
8. ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma.
Lassus H; Leminen A; Vayrynen A; Cheng G; Gustafsson JA; Isola J; Butzow R
Gynecol Oncol; 2004 Jan; 92(1):31-9. PubMed ID: 14751135
[TBL] [Abstract][Full Text] [Related]
9. Copy number variations in DCC/18q and ERBB2/17q are associated with disease-free survival in microsatellite stable colon cancer.
Sefrioui D; Vermeulin T; Blanchard F; Chapusot C; Beaussire L; Armengol-Debeir L; Sesboué R; Gangloff A; Hebbar M; Copin MC; Houivet E; Schwarz L; Clatot F; Tuech JJ; Bénichou J; Martin L; Bouvier AM; Sabourin JC; Sarafan-Vasseur N; Frébourg T; Lepage C; Michel P; Di Fiore F
Int J Cancer; 2017 Apr; 140(7):1653-1661. PubMed ID: 28006840
[TBL] [Abstract][Full Text] [Related]
10. Copy number analysis of c-erb-B2 (HER-2/neu) and topoisomerase IIalpha genes in breast carcinoma by quantitative real-time polymerase chain reaction using hybridization probes and fluorescence in situ hybridization.
Murthy SK; Magliocco AM; Demetrick DJ
Arch Pathol Lab Med; 2005 Jan; 129(1):39-46. PubMed ID: 15628907
[TBL] [Abstract][Full Text] [Related]
11. Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine.
Yang JW; Choi YL
Pathol Res Pract; 2017 Jul; 213(7):836-841. PubMed ID: 28554745
[TBL] [Abstract][Full Text] [Related]
12. TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2.
Zhang L; Gao Y; Zhang X; Guo M; Yang J; Cui H; Kong P; Niu X; Bi Y; Xu J; Yan T; Ma Y; Yang J; Qian Y; Wang F; Li H; Liu F; Cheng X; Cui Y
Theranostics; 2020; 10(24):11339-11358. PubMed ID: 33042286
[No Abstract] [Full Text] [Related]
13. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
14. Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer.
Azad TD; Chaudhuri AA; Fang P; Qiao Y; Esfahani MS; Chabon JJ; Hamilton EG; Yang YD; Lovejoy A; Newman AM; Kurtz DM; Jin M; Schroers-Martin J; Stehr H; Liu CL; Hui AB; Patel V; Maru D; Lin SH; Alizadeh AA; Diehn M
Gastroenterology; 2020 Feb; 158(3):494-505.e6. PubMed ID: 31711920
[TBL] [Abstract][Full Text] [Related]
15. Consistent and differential genetic aberrations between esophageal dysplasia and squamous cell carcinoma detected by array comparative genomic hybridization.
Shi ZZ; Shang L; Jiang YY; Hao JJ; Zhang Y; Zhang TT; Lin DC; Liu SG; Wang BS; Gong T; Zhan QM; Wang MR
Clin Cancer Res; 2013 Nov; 19(21):5867-78. PubMed ID: 24009147
[TBL] [Abstract][Full Text] [Related]
16. Expression of livin and vascular endothelial growth factor in different clinical stages of human esophageal carcinoma.
Chen L; Ren GS; Li F; Sun SQ
World J Gastroenterol; 2008 Oct; 14(37):5749-54. PubMed ID: 18837095
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of
Ecke TH; Kiani A; Schlomm T; Friedersdorff F; Rabien A; Jung K; Kilic E; Boström P; Tervahartiala M; Taimen P; Gleichenhagen J; Johnen G; Brüning T; Koch S; Roggisch J; Wirtz RM
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050010
[TBL] [Abstract][Full Text] [Related]
18. Detection of erbB-2 amplifications in tumors and sera from esophageal carcinoma patients.
Chiang PW; Beer DG; Wei WL; Orringer MB; Kurnit DM
Clin Cancer Res; 1999 Jun; 5(6):1381-6. PubMed ID: 10389922
[TBL] [Abstract][Full Text] [Related]
19. Overexpression and interactions of interleukin-10, transforming growth factor beta, and vascular endothelial growth factor in esophageal squamous cell carcinoma.
Gholamin M; Moaven O; Memar B; Farshchian M; Naseh H; Malekzadeh R; Sotoudeh M; Rajabi-Mashhadi MT; Forghani MN; Farrokhi F; Abbaszadegan MR
World J Surg; 2009 Jul; 33(7):1439-45. PubMed ID: 19440651
[TBL] [Abstract][Full Text] [Related]
20. Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome.
Hoffmann AC; Vallböhmer D; Prenzel K; Metzger R; Heitmann M; Neiss S; Ling F; Hölscher AH; Schneider PM; Brabender J
J Cancer Res Clin Oncol; 2009 Sep; 135(9):1231-7. PubMed ID: 19259700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
